HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anchao Yang Selected Research

Parkinson Disease (Parkinson's Disease)

3/2024Individual Structural Covariance Network Predicts Long-Term Motor Improvement in Parkinson's Disease with STN-DBS.
3/2024Subthalamic nucleus deep brain stimulation alleviates oxidative stress via mitophagy in Parkinson's disease.
3/2023Adaptive deep brain stimulation for Parkinson's disease: looking back at the past decade on motor outcomes.
2/2023Deep Brain Stimulation Electrode Reconstruction: Comparison between Lead-DBS and Surgical Planning System.
1/2023Prefrontal association of subthalamic deep brain stimulation with rapid eye movement sleep behavior disorder in Parkinson's disease.
1/2023Premature drug reduction after subthalamic nucleus deep brain stimulation leading to worse depression in patients with Parkinson's disease.
1/2023Closed-Loop Adaptive Deep Brain Stimulation in Parkinson's Disease: Procedures to Achieve It and Future Perspectives.
1/2023Sleep outcomes and related factors in Parkinson's disease after subthalamic deep brain electrode implantation: a retrospective cohort study.
1/2022Differential Effects of Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation on Motor Subtypes in Parkinson's Disease.
1/2022Low-frequency oscillations link frontal and parietal cortex with subthalamic nucleus in conflicts.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anchao Yang Research Topics

Disease

16Parkinson Disease (Parkinson's Disease)
03/2024 - 01/2019
5Dystonia (Limb Dystonia)
01/2024 - 03/2019
2Movement Disorders (Movement Disorder)
01/2023 - 10/2021
2Epilepsy (Aura)
12/2022 - 01/2011
2Drug Resistant Epilepsy
04/2014 - 01/2014
1Tourette Syndrome (Tourette's Syndrome)
02/2024
1Meige Syndrome
01/2024
1REM Sleep Behavior Disorder
01/2023
1Essential Tremor (Essential Tremors)
01/2022
1Tremor (Tremors)
01/2022
1Pneumocephalus
01/2022
1Disease Progression
01/2022
1Pain (Aches)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Huntington Disease (Huntington's Disease)
11/2020
1Dystonic Disorders (Writer's Cramp)
03/2019
1Seizures (Absence Seizure)
01/2014
1Temporal Lobe Epilepsy
01/2011

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
01/2023 - 12/2022
1Levodopa (L Dopa)FDA LinkGeneric
05/2021
1salicylhydroxamic acid (SHAM)IBA
03/2019
1Therapeutic UsesIBA
01/2014
1Kainic Acid (Kainate)IBA
01/2011

Therapy/Procedure

24Deep Brain Stimulation
03/2024 - 01/2011
5Therapeutics
01/2024 - 01/2014
5Electrodes (Electrode)
02/2023 - 01/2022
2Vagus Nerve Stimulation
04/2014 - 01/2014
1Activities of Daily Living (ADL)
01/2022
1Punctures
01/2022